MOLLIE MCGUIRE: Open Payments
NPI 1922573435 · JOHNSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,689 in 105 payments from 14 companies in 2025. Trend: 2023 $2,819 · 2024 $3,483 · 2025 $2,689
Food & beverage: $2,652Education: $37
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 39 | $1,227 |
| Regeneron Healthcare Solutions, Inc. | 15 | $302 |
| GENZYME CORPORATION | 11 | $221 |
| Amgen Inc. | 11 | $220 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $125 |
| Viatris Specialty LLC | 6 | $117 |
| Grifols USA, LLC | 5 | $111 |
| Philips North America LLC | 5 | $90 |
| Actelion Pharmaceuticals US, Inc. | 1 | $68 |
| GlaxoSmithKline, LLC. | 3 | $60 |
Products named: TEZSPIRE, DUPIXENT, FASENRA, AIRSUPRA, OFEV, YUPELRI, BREZTRI, Prolastin-C Liquid.
Industry payments across PA — which companies pay providers there.
